Subsidiary26 Jun 2026, 07:10 pm
Wanbury Ltd Approves Subsidiary Incorporation and Auditor Appointments
AI Summary
Wanbury Ltd's Board of Directors, in a meeting held on June 26, 2026, approved the incorporation of a new subsidiary in India with an estimated capital outlay of ₹4,10,000. The subsidiary, tentatively named Wanbury Skin Health Limited, will operate in the pharmaceutical industry. The board also appointed M/s. Ernst & Young LLP as the Internal Auditor and M/s. ABK & Associates as the Cost Auditor for the Financial Year 2026-2027. The meeting commenced at 3:35 p.m. and concluded at 4:15 p.m.
Key Highlights
- Board approved incorporation of a new subsidiary in India.
- Estimated capital outlay for the subsidiary is ₹4,10,000.
- Ernst & Young LLP appointed as Internal Auditor for FY27.
- ABK & Associates appointed as Cost Auditor for FY27.
Price Impact
More from WANBURY